Completed Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis NCT00035334 Conditions Amyloidosis, Arthritis, Arthritis, Rheumatoid, +32 more Locations Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, — Indianapolis, Indiana, United States Boston Medical Center, Renal Division — Boston, Massachusetts, United States Mayo Clinic — Rochester, Minnesota, United States Mount Sinai Medical Center — New York, United States View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
